ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 987

Death Certificates Do Not Accurately Identify SLE Patients

Kelly Kaysen, Cristina Drenkard, Gaobin Bao and S. Sam Lim, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: death, epidemiologic methods and morbidity and mortality, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Mortality rates are higher in SLE patients compared to the general population, and research on SLE mortality is ongoing. The majority of mortality studies have relied on death certificates to identify SLE patients. However, this approach may misclassify cases and include both false positives and negatives. The rate of misclassification on death certificates is unclear. Using a large population-based registry of validated SLE patients, we sought to ascertain the accuracy of death certificates in identifying SLE patients.

Methods:   The Georgia Lupus Registry (GLR) is a population-based registry of validated SLE patients living in Atlanta, GA from 2002-04. The state HIPAA exemption for surveillance allowed health care providers and facilities to provide access to protected health information without written patient consent. Patients were validated by meeting ≥4 ACR criteria or 3 ACR criteria with a final diagnosis of SLE by a board-certified rheumatologist. These patients were matched to the Georgia Office of Vital Records death certificates through 2013. The primary, secondary, tertiary, and contributing causes of death were identified on the death certificates using ICD-10 codes.

Results:   State death certificates matched with 321 SLE patients from the GLR through 2013.  Only 24.6% (79/321) of patients had SLE listed on the death certificate. Characteristics of the deceased SLE patients are listed in the below table. While there were no significant differences with race and sex, SLE patients captured in death certificates were much younger at SLE diagnosis and died at a younger age.

Conclusion:   In a population-based registry with many high-risk black SLE patients, SLE was recorded on the death certificates of only 24.6% of deaths. SLE was listed more often on the death certificates of those who were younger at SLE diagnosis and death, perhaps indicating more severe disease or increased awareness by the caring providers. Death certificates do not accurately capture the full spectrum of SLE patients. Reliance on death certificates to obtain SLE mortality data will underestimate the burden of the disease.

 

Characteristics of deceased SLE patients and identification of SLE on death certificates

Characteristic

Category

Overall

(n=321)

SLE captured in death certificate

No (n=242)

Yes (n=79)

P Value

Sex, n (%)

Male

44 (13.7)

37 (84.1)

7 (15.9)

0.15

Female

277 (86.3)

205 (74.0)

72 (26.0)

Race, n (%)

White

58 (18.1)

47 (81.0)

11 (19.0)

0.27

Black

263 (81.9)

195 (74.1)

68 (25.9)

Age at diagnosis (years)

Mean ± SD

39.1 ± 17.6

41.0 ± 17.5

33.4 ± 16.6

0.0008

Age at death (years)

Mean ± SD

52.7 ± 17.3

55.5 ± 16.4

44.4 ± 17.6

<0.0001

 


Disclosure: K. Kaysen, None; C. Drenkard, None; G. Bao, None; S. S. Lim, None.

To cite this abstract in AMA style:

Kaysen K, Drenkard C, Bao G, Lim SS. Death Certificates Do Not Accurately Identify SLE Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/death-certificates-do-not-accurately-identify-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/death-certificates-do-not-accurately-identify-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology